Private Advisor Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33
Closed -$1K 2027
2022
Q3
$1K Sell
33
-37
-53% -$1.3K ﹤0.01% 1907
2022
Q2
$4K Buy
70
+37
+112% +$2.75K ﹤0.01% 2104
2022
Q1
$5K Hold
33
﹤0.01% 2086
2021
Q4
$6K Sell
33
-2
-6% -$746 ﹤0.01% 2132
2021
Q3
$17K Hold
35
﹤0.01% 2001
2021
Q2
$18K Sell
35
-3
-8% -$1.61K ﹤0.01% 1958
2021
Q1
$19K Hold
38
﹤0.01% 1871
2020
Q4
$18K Buy
38
+3
+9% +$984 ﹤0.01% 1749
2020
Q3
$10K Hold
35
﹤0.01% 1551
2020
Q2
$7K Buy
+35
New +$5.82K ﹤0.01% 3121
2019
Q4
Sell
-42
Closed -$6K 1765
2019
Q3
$6K Buy
+42
New +$5.6K ﹤0.01% 1651
2019
Q1
Sell
-68
Closed -$8K 1621
2018
Q4
$8K Sell
68
-4
-6% -$614 ﹤0.01% 1348
2018
Q3
$11K Buy
+72
New +$30.1K ﹤0.01% 1581
2018
Q2
Sell
-94
Closed -$96K 1480
2018
Q1
$96K Buy
94
+54
+135% +$45.2K ﹤0.01% 1109
2017
Q4
$36K Sell
40
-2
-5% -$940 ﹤0.01% 1170
2017
Q3
$10K Hold
42
﹤0.01% 1458
2017
Q2
$7K Hold
42
﹤0.01% 1374
2017
Q1
$8K Hold
42
﹤0.01% 1406
2016
Q4
$12K Hold
42
﹤0.01% 1268
2016
Q3
$10K Buy
+42
New +$11.8K ﹤0.01% 1124

Other funds holding AMPE

Private Advisor Group's AMPE Position: Q4 2022 in Review

Private Advisor Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 33 shares — an estimated $1K sold.

Private Advisor Group first reported a position in AMPE in Q3 2016 and held it in 20 quarters. The position peaked at $96K in Q1 2018. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Private Advisor Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 33 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Private Advisor Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2016 and held it in 20 quarters.
  • Private Advisor Group's Ampio Pharmaceuticals Inc. position peaked at $96K in Q1 2018.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.